Abstract
Diabetes mellitus (DM) is a severe chronic diseases with a global prevalence of 9%, leading to poor health and high health care costs, and is a direct cause of millions of deaths each year. The rising epidemic of diabetes and its complications, such as retinal and peripheral nerve disease, is a huge burden globally. A better understanding of the molecular pathways involved in the development and progression of diabetes and its complications can facilitate individualized prevention and treatment. High diabetes mellitus incidence rate is caused mainly by lack of non-invasive and reliable methods for early diagnosis, such as plasma biomarkers. The incidence of diabetes and its complications in the world still grows so it is crucial to develop a new, faster, high specificity and more sensitive diagnostic technologies. With the advancement of analytical techniques, metabolomics can identify and quantify multiple biomarkers simultaneously in a high-throughput manner, and effective biomarkers can greatly improve the efficiency of diabetes and its complications. By providing information on potential metabolic pathways, metabolomics can further define the mechanisms underlying the progression of diabetes and its complications, help identify potential therapeutic targets, and improve the prevention and management of T2D and its complications. The application of amino acid metabolomics in epidemiological studies has identified new biomarkers of diabetes mellitus (DM) and its complications, such as branched-chain amino acids, phenylalanine and arginine metabolites. This study focused on the analysis of metabolic amino acid profiling as a method for identifying biomarkers for the detection and screening of diabetes and its complications. The results presented are all from recent studies, and in all cases analyzed, there were significant changes in the amino acid profile of patients in the experimental group compared to the control group. This study demonstrates the potential of amino acid profiles as a detection method for diabetes and its complications.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
Data availability
Data availability is not applicable to this article as no new data were created or analyzed in this study.
References
Abdelsattar S, Kasemy ZA, Elsayed M, Elrahem TA, Zewain SK (2021) Targeted metabolomics as a tool for the diagnosis of kidney disease in type II diabetes mellitus. Br J Biomed Sci 78:184–190. https://doi.org/10.1080/09674845.2021.1894705
Abhary S, Kasmeridis N, Burdon KP, Kuot A, Whiting MJ, Yew WP, Petrovsky N, Craig JE (2009) Diabetic retinopathy is associated with elevated serum asymmetric and symmetric dimethylarginines. Diabetes Care 32:2084–2086. https://doi.org/10.2337/dc09-0816
Ackermann PW, Hart DA (2013) Influence of comorbidities: neuropathy, vasculopathy, and diabetes on healing response quality. Adv Wound Care (New Rochelle) 2:410–421. https://doi.org/10.1089/wound.2012.0437
American Diabetes A (2020) 11. Microvascular complications and foot care: standards of medical care in diabetes-2020. Diabetes Care 43:S135–S151. https://doi.org/10.2337/dc20-S011
Atila A, Alay H, Yaman ME, Akman TC, Cadirci E, Bayrak B, Celik S, Atila NE, Yaganoglu AM, Kadioglu Y, Halici Z, Parlak E, Bayraktutan Z (2021) The serum amino acid profile in COVID-19. Amino Acids 53:1569–1588. https://doi.org/10.1007/s00726-021-03081-w
Baker M (2005) In biomarkers we trust? Nat Biotechnol 23:297–304. https://doi.org/10.1038/nbt0305-297
Barutta F, Bellini S, Canepa S, Durazzo M, Gruden G (2021) Novel biomarkers of diabetic kidney disease: current status and potential clinical application. Acta Diabetol 58:819–830. https://doi.org/10.1007/s00592-020-01656-9
Beale DJ, Pinu FR, Kouremenos KA, Poojary MM, Narayana VK, Boughton BA, Kanojia K, Dayalan S, Jones OAH, Dias DA (2018) Review of recent developments in GC-MS approaches to metabolomics-based research. Metabolomics 14:152. https://doi.org/10.1007/s11306-018-1449-2
Bloomgarden Z (2018) Diabetes and branched-chain amino acids: What is the link? J Diabetes 10:350–352. https://doi.org/10.1111/1753-0407.12645
Boulton AJ, Vinik AI, Arezzo JC, Bril V, Feldman EL, Freeman R, Malik RA, Maser RE, Sosenko JM, Ziegler D, American Diabetes A (2005) Diabetic neuropathies: a statement by the American Diabetes Association. Diabetes Care 28:956–962. https://doi.org/10.2337/diacare.28.4.956
Brazionis L, Rowley K Sr, Itsiopoulos C, Harper CA, O’Dea K (2008) Homocysteine and diabetic retinopathy. Diabetes Care 31:50–56. https://doi.org/10.2337/dc07-0632
Brosnan JT (2003) Interorgan amino acid transport and its regulation. J Nutr 133:2068S-2072S. https://doi.org/10.1093/jn/133.6.2068S
Cabrera O, Jacques-Silva MC, Speier S, Yang SN, Kohler M, Fachado A, Vieira E, Zierath JR, Kibbey R, Berman DM, Kenyon NS, Ricordi C, Caicedo A, Berggren PO (2008) Glutamate is a positive autocrine signal for glucagon release. Cell Metab 7:545–554. https://doi.org/10.1016/j.cmet.2008.03.004
Ceglarek U, Leichtle A, Brugel M, Kortz L, Brauer R, Bresler K, Thiery J, Fiedler GM (2009) Challenges and developments in tandem mass spectrometry based clinical metabolomics. Mol Cell Endocrinol 301:266–271. https://doi.org/10.1016/j.mce.2008.10.013
Chen T, Ni Y, Ma X, Bao Y, Liu J, Huang F, Hu C, Xie G, Zhao A, Jia W, Jia W (2016) Branched-chain and aromatic amino acid profiles and diabetes risk in Chinese populations. Sci Rep 6:20594. https://doi.org/10.1038/srep20594
Chen Y, Wang N, Dong X, Zhu J, Chen Y, Jiang Q, Fu C (2021) Associations between serum amino acids and incident type 2 diabetes in Chinese rural adults. Nutr Metab Cardiovasc Dis 31:2416–2425. https://doi.org/10.1016/j.numecd.2021.05.004
Cheung N, Mitchell P, Wong TY (2010) Diabetic retinopathy. Lancet 376:124–136. https://doi.org/10.1016/S0140-6736(09)62124-3
Chou CA, Lin CN, Chiu DT, Chen IW, Chen ST (2018) Tryptophan as a surrogate prognostic marker for diabetic nephropathy. J Diabetes Investig 9:366–374. https://doi.org/10.1111/jdi.12707
Cole JB, Florez JC (2020) Genetics of diabetes mellitus and diabetes complications. Nat Rev Nephrol 16:377–390. https://doi.org/10.1038/s41581-020-0278-5
Colhoun HM, Marcovecchio ML (2018) Biomarkers of diabetic kidney disease. Diabetologia 61:996–1011. https://doi.org/10.1007/s00125-018-4567-5
Delgado-Povedano MM, Calderon-Santiago M, Priego-Capote F, de Castro MDL (2016) Study of sample preparation for quantitative analysis of amino acids in human sweat by liquid chromatography-tandem mass spectrometry. Talanta 146:310–317. https://doi.org/10.1016/j.talanta.2015.07.066
Dunn WB, Broadhurst D, Ellis DI, Brown M, Halsall A, O’Hagan S, Spasic I, Tseng A, Kell DB (2008) A GC-TOF-MS study of the stability of serum and urine metabolomes during the UK Biobank sample collection and preparation protocols. Int J Epidemiol 37(Suppl 1):i23-30. https://doi.org/10.1093/ije/dym281
Dunn WB, Broadhurst DI, Atherton HJ, Goodacre R, Griffin JL (2011) Systems level studies of mammalian metabolomes: the roles of mass spectrometry and nuclear magnetic resonance spectroscopy. Chem Soc Rev 40:387–426. https://doi.org/10.1039/b906712b
Emwas AH, Roy R, McKay RT, Ryan D, Brennan L, Tenori L, Luchinat C, Gao X, Zeri AC, Gowda GA, Raftery D, Steinbeck C, Salek RM, Wishart DS (2016) Recommendations and standardization of biomarker quantification using NMR-based metabolomics with particular focus on urinary analysis. J Proteome Res 15:360–373. https://doi.org/10.1021/acs.jproteome.5b00885
Feldman EL, Nave KA, Jensen TS, Bennett DLH (2017) New horizons in diabetic neuropathy: mechanisms, bioenergetics, and pain. Neuron 93:1296–1313. https://doi.org/10.1016/j.neuron.2017.02.005
Felig P, Marliss E Jr, Cahill GF (1969) Plasma amino acid levels and insulin secretion in obesity. N Engl J Med 281:811–816. https://doi.org/10.1056/NEJM196910092811503
Floegel A, Stefan N, Yu Z, Muhlenbruch K, Drogan D, Joost HG, Fritsche A, Haring HU, Hrabe de Angelis M, Peters A, Roden M, Prehn C, Wang-Sattler R, Illig T, Schulze MB, Adamski J, Boeing H, Pischon T (2013) Identification of serum metabolites associated with risk of type 2 diabetes using a targeted metabolomic approach. Diabetes 62:639–648. https://doi.org/10.2337/db12-0495
Fridman V, Zarini S, Sillau S, Harrison K, Bergman BC, Feldman EL, Reusch JEB, Callaghan BC (2021) Altered plasma serine and 1-deoxydihydroceramide profiles are associated with diabetic neuropathy in type 2 diabetes and obesity. J Diabetes Complications 35:107852. https://doi.org/10.1016/j.jdiacomp.2021.107852
Furey A, Moriarty M, Bane V, Kinsella B, Lehane M (2013) Ion suppression; a critical review on causes, evaluation, prevention and applications. Talanta 115:104–122. https://doi.org/10.1016/j.talanta.2013.03.048
Furlani IL, da Cruz NE, Canuto GAB, Macedo AN, Oliveira RV (2021) Liquid chromatography-mass spectrometry for clinical metabolomics: an overview. Adv Exp Med Biol 1336:179–213. https://doi.org/10.1007/978-3-030-77252-9_10
Gao L, Wang J, Yin Y (2020a) Interpretation of 2019 international working group on diabetic foot guidelines on the prevention and management of diabetic foot disease. Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi 34:16–20. https://doi.org/10.7507/1002-1892.201906014
Gao X, Hou R, Li X, Qiu XH, Luo HH, Liu SL, Fang ZZ (2020b) The association between leucine and diabetic nephropathy in different gender: a cross-sectional study in Chinese patients with type 2 diabetes. Front Endocrinol (lausanne). 11:619422. https://doi.org/10.3389/fendo.2020.619422
Gar C, Rottenkolber M, Prehn C, Adamski J, Seissler J, Lechner A (2018) Serum and plasma amino acids as markers of prediabetes, insulin resistance, and incident diabetes. Crit Rev Clin Lab Sci 55:21–32. https://doi.org/10.1080/10408363.2017.1414143
Gazzaruso C, Coppola A, Montalcini T, Baffero E, Garzaniti A, Pelissero G, Collaviti S, Grugnetti A, Gallotti P, Pujia A, Solerte SB, Giustina A (2012) Lipoprotein(a) and homocysteine as genetic risk factors for vascular and neuropathic diabetic foot in type 2 diabetes mellitus. Endocrine 41:89–95. https://doi.org/10.1007/s12020-011-9544-4
Ghanem AA, Elewa A, Arafa LF (2011) Pentosidine and N-carboxymethyl-lysine: biomarkers for type 2 diabetic retinopathy. Eur J Ophthalmol 21:48–54. https://doi.org/10.5301/ejo.2010.4447
Gonzalez R, Pedro T, Real JT, Martinez-Hervas S, Abellan MR, Lorente R, Priego A, Catala M, Chaves FJ, Ascaso JF, Carmena R (2010) Plasma homocysteine levels are associated with ulceration of the foot in patients with type 2 diabetes mellitus. Diabetes Metab Res Rev 26:115–120. https://doi.org/10.1002/dmrr.1061
Guasch-Ferre M, Hruby A, Toledo E, Clish CB, Martinez-Gonzalez MA, Salas-Salvado J, Hu FB (2016) Metabolomics in prediabetes and diabetes: a systematic review and meta-analysis. Diabetes Care 39:833–846. https://doi.org/10.2337/dc15-2251
Hall JA, Yerramilli M, Obare E, Yerramilli M, Almes K, Jewell DE (2016) Serum concentrations of symmetric dimethylarginine and creatinine in dogs with naturally occurring chronic kidney disease. J Vet Intern Med 30:794–802. https://doi.org/10.1111/jvim.13942
Hanai K, Babazono T, Nyumura I, Toya K, Tanaka N, Tanaka M, Ishii A, Iwamoto Y (2009) Asymmetric dimethylarginine is closely associated with the development and progression of nephropathy in patients with type 2 diabetes. Nephrol Dial Transplant 24:1884–1888. https://doi.org/10.1093/ndt/gfn716
Hosseinkhani S, Arjmand B, Dilmaghani-Marand A, Mohammadi Fateh S, Dehghanbanadaki H, Najjar N, Alavi-Moghadam S, Ghodssi-Ghassemabadi R, Nasli-Esfahani E, Farzadfar F, Larijani B, Razi F (2022) Targeted metabolomics analysis of amino acids and acylcarnitines as risk markers for diabetes by LC-MS/MS technique. Sci Rep 12:8418. https://doi.org/10.1038/s41598-022-11970-7
Huang EJ, Kuo WW, Chen YJ, Chen TH, Chang MH, Lu MC, Tzang BS, Hsu HH, Huang CY, Lee SD (2006) Homocysteine and other biochemical parameters in type 2 diabetes mellitus with different diabetic duration or diabetic retinopathy. Clin Chim Acta 366:293–298. https://doi.org/10.1016/j.cca.2005.10.025
Hung SY, Tsai JS, Yeh JT, Chen KH, Lin CN, Yang HM, Lin CW, Chen HY, Huang CH, Huang YY (2019) Amino acids and wound healing in people with limb-threatening diabetic foot ulcers. J Diabetes Complications 33:107403. https://doi.org/10.1016/j.jdiacomp.2019.06.008
Ichikawa S, Gohda T, Murakoshi M, Li Z, Adachi E, Koshida T, Suzuki Y (2020) Aspartic acid supplementation ameliorates symptoms of diabetic kidney disease in mice. FEBS Open Bio 10:1122–1134. https://doi.org/10.1002/2211-5463.12862
Jacob M, Lopata AL, Dasouki M, Abdel Rahman AM (2019) Metabolomics toward personalized medicine. Mass Spectrom Rev 38:221–238. https://doi.org/10.1002/mas.21548
Jang C, Chen L, Rabinowitz JD (2018) Metabolomics and isotope tracing. Cell 173:822–837. https://doi.org/10.1016/j.cell.2018.03.055
Jin H, Zhu B, Liu X, Jin J, Zou H (2019) Metabolic characterization of diabetic retinopathy: an (1)H-NMR-based metabolomic approach using human aqueous humor. J Pharm Biomed Anal 174:414–421. https://doi.org/10.1016/j.jpba.2019.06.013
Johnson CH, Ivanisevic J, Siuzdak G (2016) Metabolomics: beyond biomarkers and towards mechanisms. Nat Rev Mol Cell Biol 17:451–459. https://doi.org/10.1038/nrm.2016.25
Jones MS, Rivera M, Puccinelli CL, Wang MY, Williams SJ, Barber AE (2014) Targeted amino acid supplementation in diabetic foot wounds: pilot data and a review of the literature. Surg Infect (larchmt) 15:708–712. https://doi.org/10.1089/sur.2013.158
Kastelan S, Oreskovic I, Biscan F, Kastelan H, Gverovic Antunica A (2020) Inflammatory and angiogenic biomarkers in diabetic retinopathy. Biochem Med (zagreb). 30:030502. https://doi.org/10.11613/BM.2020.030502
Khamis MM, Adamko DJ, El-Aneed A (2017) Mass spectrometric based approaches in urine metabolomics and biomarker discovery. Mass Spectrom Rev 36:115–134. https://doi.org/10.1002/mas.21455
Kim SJ, Song HE, Lee HY, Yoo HJ (2021) Mass spectrometry-based metabolomics in translational research. Adv Exp Med Biol 1310:509–531. https://doi.org/10.1007/978-981-33-6064-8_19
Kowluru RA, Engerman RL, Case GL, Kern TS (2001) Retinal glutamate in diabetes and effect of antioxidants. Neurochem Int 38:385–390. https://doi.org/10.1016/s0197-0186(00)00112-1
Laakso M (2019) Biomarkers for type 2 diabetes. Mol Metab 27S:S139–S146. https://doi.org/10.1016/j.molmet.2019.06.016
Lai M, Liu Y, Ronnett GV, Wu A, Cox BJ, Dai FF, Rost HL, Gunderson EP, Wheeler MB (2020) Amino acid and lipid metabolism in post-gestational diabetes and progression to type 2 diabetes: a metabolic profiling study. PLoS Med 17:e1003112. https://doi.org/10.1371/journal.pmed.1003112
Lavery LA, Peters EJ, Williams JR, Murdoch DP, Hudson A, Lavery DC, International Working Group on the Diabetic F (2008) Reevaluating the way we classify the diabetic foot: restructuring the diabetic foot risk classification system of the International Working Group on the Diabetic Foot. Diabetes Care 31:154–156. https://doi.org/10.2337/dc07-1302
Lee R, Wong TY, Sabanayagam C (2015) Epidemiology of diabetic retinopathy, diabetic macular edema and related vision loss. Eye vis (lond) 2:17. https://doi.org/10.1186/s40662-015-0026-2
Lei Z, Huhman DV, Sumner LW (2011) Mass spectrometry strategies in metabolomics. J Biol Chem 286:25435–25442. https://doi.org/10.1074/jbc.R111.238691
Li Q, Puro DG (2002) Diabetes-induced dysfunction of the glutamate transporter in retinal Muller cells. Invest Ophthalmol vis Sci 43:3109–3116
Li J, Shi M, Zhang H, Yan L, Xie M, Zhuang L, Zhu Y, Chen J (2012) Relation of homocysteine to early nephropathy in patients with Type 2 diabetes. Clin Nephrol 77:305–310. https://doi.org/10.5414/cn107296
Li Y, Yao W, Gao Y (2022) Effects of Tang Luo Ning on diabetic peripheral neuropathy in rats revealed by LC-MS metabolomics approach. Biomed Chromatogr 36:e5374. https://doi.org/10.1002/bmc.5374
Lieth E, LaNoue KF, Antonetti DA, Ratz M (2000) Diabetes reduces glutamate oxidation and glutamine synthesis in the retina. The Penn State Retina Research Group. Exp Eye Res 70:723–730. https://doi.org/10.1006/exer.2000.0840
Liu JJ, Ghosh S, Kovalik JP, Ching J, Choi HW, Tavintharan S, Ong CN, Sum CF, Summers SA, Tai ES, Lim SC (2017) Profiling of plasma metabolites suggests altered mitochondrial fuel usage and remodeling of sphingolipid metabolism in individuals with type 2 diabetes and kidney disease. Kidney Int Rep 2:470–480. https://doi.org/10.1016/j.ekir.2016.12.003
Long J, Liu L, Jia Q, Yang Z, Sun Z, Yan C, Yan D (2020) Integrated biomarker for type 2 diabetes mellitus and impaired fasting glucose based on metabolomics analysis using ultra-high performance liquid chromatography quadrupole-Orbitrap high-resolution accurate mass spectrometry. Rapid Commun Mass Spectrom 34:e8779. https://doi.org/10.1002/rcm.8779
Looker HC, Fagot-Campagna A, Gunter EW, Pfeiffer CM, Narayan KM, Knowler WC, Hanson RL (2003) Homocysteine as a risk factor for nephropathy and retinopathy in type 2 diabetes. Diabetologia 46:766–772. https://doi.org/10.1007/s00125-003-1104-x
Looker HC, Colombo M, Hess S, Brosnan MJ, Farran B, Dalton RN, Wong MC, Turner C, Palmer CN, Nogoceke E, Groop L, Salomaa V, Dunger DB, Agakov F, McKeigue PM, Colhoun HM, Investigators S (2015) Biomarkers of rapid chronic kidney disease progression in type 2 diabetes. Kidney Int 88:888–896. https://doi.org/10.1038/ki.2015.199
Lopez N, Sanchez J, Palou A, Serra F (2018) Gender-associated impact of early leucine supplementation on adult predisposition to obesity in rats. Nutrients. https://doi.org/10.3390/nu10010076
Lu W, Su X, Klein MS, Lewis IA, Fiehn O, Rabinowitz JD (2017) Metabolite measurement: pitfalls to avoid and practices to follow. Annu Rev Biochem 86:277–304. https://doi.org/10.1146/annurev-biochem-061516-044952
Malaguarnera G, Gagliano C, Giordano M, Salomone S, Vacante M, Bucolo C, Caraci F, Reibaldi M, Drago F, Avitabile T, Motta M (2014) Homocysteine serum levels in diabetic patients with non proliferative, proliferative and without retinopathy. Biomed Res Int 2014:191497. https://doi.org/10.1155/2014/191497
Malecki MT, Undas A, Cyganek K, Mirkiewicz-Sieradzka B, Wolkow P, Osmenda G, Walus-Miarka M, Guzik TJ, Sieradzki J (2007) Plasma asymmetric dimethylarginine (ADMA) is associated with retinopathy in type 2 diabetes. Diabetes Care 30:2899–2901. https://doi.org/10.2337/dc07-1138
Markley JL, Bruschweiler R, Edison AS, Eghbalnia HR, Powers R, Raftery D, Wishart DS (2017) The future of NMR-based metabolomics. Curr Opin Biotechnol 43:34–40. https://doi.org/10.1016/j.copbio.2016.08.001
Mathew AV, Jaiswal M, Ang L, Michailidis G, Pennathur S, Pop-Busui R (2019) Impaired amino acid and TCA metabolism and cardiovascular autonomic neuropathy progression in type 1 diabetes. Diabetes 68:2035–2044. https://doi.org/10.2337/db19-0145
McGarrah RW, Crown SB, Zhang GF, Shah SH, Newgard CB (2018) Cardiovascular metabolomics. Circ Res 122:1238–1258. https://doi.org/10.1161/CIRCRESAHA.117.311002
Merino J, Leong A, Liu CT, Porneala B, Walford GA, von Grotthuss M, Wang TJ, Flannick J, Dupuis J, Levy D, Gerszten RE, Florez JC, Meigs JB (2018) Metabolomics insights into early type 2 diabetes pathogenesis and detection in individuals with normal fasting glucose. Diabetologia 61:1315–1324. https://doi.org/10.1007/s00125-018-4599-x
Mirmiran P, Bahadoran Z, Esfandyari S, Azizi F (2017) Dietary protein and amino acid profiles in relation to risk of dysglycemia: findings from a prospective population-based study. Nutrients. https://doi.org/10.3390/nu9090971
Mishra N, Saxena S, Ruia S, Prasad S, Singh V, Khanna V, Staffa R, Gaspar L, Kruzliak P (2016) Increased levels of N(epsilon)- carboxy methyl lysine (N(epsilon)-CML) are associated with topographic alterations in retinal pigment epithelium: a preliminary study. J Diabetes Complications 30:868–872. https://doi.org/10.1016/j.jdiacomp.2016.03.011
Nagana Gowda GA, Raftery D (2021) NMR-based metabolomics. Adv Exp Med Biol 1280:19–37. https://doi.org/10.1007/978-3-030-51652-9_2
Nagao K, Kimura T (2020) Use of plasma-free amino acids as biomarkers for detecting and predicting disease risk. Nutr Rev 78:79–85. https://doi.org/10.1093/nutrit/nuaa086
Nakamura H, Jinzu H, Nagao K, Noguchi Y, Shimba N, Miyano H, Watanabe T, Iseki K (2014) Plasma amino acid profiles are associated with insulin, C-peptide and adiponectin levels in type 2 diabetic patients. Nutr Diabetes 4:e133. https://doi.org/10.1038/nutd.2014.32
Nalysnyk L, Hernandez-Medina M, Krishnarajah G (2010) Glycaemic variability and complications in patients with diabetes mellitus: evidence from a systematic review of the literature. Diabetes Obes Metab 12:288–298. https://doi.org/10.1111/j.1463-1326.2009.01160.x
Nicholson JK, Connelly J, Lindon JC, Holmes E (2002) Metabonomics: a platform for studying drug toxicity and gene function. Nat Rev Drug Discov 1:153–161. https://doi.org/10.1038/nrd728
Paisey RB, Abbott A, Paisey CF, Walker D (2019) Diabetic foot ulcer incidence and survival with improved diabetic foot services: an 18-year study. Diabet Med 36:1424–1430. https://doi.org/10.1111/dme.14045
Papadopoulou-Marketou N, Chrousos GP, Kanaka-Gantenbein C (2017) Diabetic nephropathy in type 1 diabetes: a review of early natural history, pathogenesis, and diagnosis. Diabetes Metab Res Rev. https://doi.org/10.1002/dmrr.2841
Park S, Rhee SY, Jeong SJ, Kim K, Chon S, Yu SY, Woo JT (2017) Features of long-standing korean type 2 diabetes mellitus patients with diabetic retinopathy: a study based on standardized clinical data. Diabetes Metab J 41:393–404. https://doi.org/10.4093/dmj.2017.41.5.393
Park SY, Kim J, Son JI, Rhee SY, Kim DY, Chon S, Lim H, Woo JT (2021) Dietary glutamic acid and aspartic acid as biomarkers for predicting diabetic retinopathy. Sci Rep 11:7244. https://doi.org/10.1038/s41598-021-83165-5
Pena MJ, Lambers Heerspink HJ, Hellemons ME, Friedrich T, Dallmann G, Lajer M, Bakker SJ, Gansevoort RT, Rossing P, de Zeeuw D, Roscioni SS (2014) Urine and plasma metabolites predict the development of diabetic nephropathy in individuals with Type 2 diabetes mellitus. Diabet Med 31:1138–1147. https://doi.org/10.1111/dme.12447
Pop-Busui R, Boulton AJ, Feldman EL, Bril V, Freeman R, Malik RA, Sosenko JM, Ziegler D (2017) Diabetic neuropathy: a position statement by the American Diabetes Association. Diabetes Care 40:136–154. https://doi.org/10.2337/dc16-2042
Rabkin R (2003) Diabetic nephropathy. Clin Cornerstone 5:1–11. https://doi.org/10.1016/s1098-3597(03)90014-7
Ramachandra Bhat L, Vedantham S, Krishnan UM, Rayappan JBB (2019) Methylglyoxal - an emerging biomarker for diabetes mellitus diagnosis and its detection methods. Biosens Bioelectron 133:107–124. https://doi.org/10.1016/j.bios.2019.03.010
Rebholz CM, Yu B, Zheng Z, Chang P, Tin A, Kottgen A, Wagenknecht LE, Coresh J, Boerwinkle E, Selvin E (2018) Serum metabolomic profile of incident diabetes. Diabetologia 61:1046–1054. https://doi.org/10.1007/s00125-018-4573-7
Rees CA, Rostad CA, Mantus G, Anderson EJ, Chahroudi A, Jaggi P, Wrammert J, Ochoa JB, Ochoa A, Basu RK, Heilman S, Harris F, Lapp SA, Hussaini L, Vos MB, Brown LA, Morris CR (2021) Altered amino acid profile in patients with SARS-CoV-2 infection. Proc Natl Acad Sci U S A. https://doi.org/10.1073/pnas.2101708118
Rhee EP (2015) Metabolomics and renal disease. Curr Opin Nephrol Hypertens 24:371–379. https://doi.org/10.1097/MNH.0000000000000136
Rhee SY, Jung ES, Park HM, Jeong SJ, Kim K, Chon S, Yu SY, Woo JT, Lee CH (2018) Plasma glutamine and glutamic acid are potential biomarkers for predicting diabetic retinopathy. Metabolomics 14:89. https://doi.org/10.1007/s11306-018-1383-3
Rhee SY, Jung ES, Suh DH, Jeong SJ, Kim K, Chon S, Yu SY, Woo JT, Lee CH (2021) Plasma amino acids and oxylipins as potential multi-biomarkers for predicting diabetic macular edema. Sci Rep 11:9727. https://doi.org/10.1038/s41598-021-88104-y
Rojas DR, Kuner R, Agarwal N (2019) Metabolomic signature of type 1 diabetes-induced sensory loss and nerve damage in diabetic neuropathy. J Mol Med (berl) 97:845–854. https://doi.org/10.1007/s00109-019-01781-1
Roointan A, Gheisari Y, Hudkins KL, Gholaminejad A (2021) Non-invasive metabolic biomarkers for early diagnosis of diabetic nephropathy: meta-analysis of profiling metabolomics studies. Nutr Metab Cardiovasc Dis 31:2253–2272. https://doi.org/10.1016/j.numecd.2021.04.021
Rumora AE, Guo K, Alakwaa FM, Andersen ST, Reynolds EL, Jorgensen ME, Witte DR, Tankisi H, Charles M, Savelieff MG, Callaghan BC, Jensen TS, Feldman EL (2021) Plasma lipid metabolites associate with diabetic polyneuropathy in a cohort with type 2 diabetes. Ann Clin Transl Neurol 8:1292–1307. https://doi.org/10.1002/acn3.51367
Ryan PJ, Riechman SE, Fluckey JD, Wu G (2021) Interorgan metabolism of amino acids in human health and disease. Adv Exp Med Biol 1332:129–149. https://doi.org/10.1007/978-3-030-74180-8_8
Saeedi P, Petersohn I, Salpea P, Malanda B, Karuranga S, Unwin N, Colagiuri S, Guariguata L, Motala AA, Ogurtsova K, Shaw JE, Bright D, Williams R, Committee IDFDA (2019) Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: results from the International Diabetes Federation Diabetes Atlas, 9(th) edition. Diabetes Res Clin Pract 157:107843. https://doi.org/10.1016/j.diabres.2019.107843
Saleem T, Dahpy M, Ezzat G, Abdelrahman G, Abdel-Aziz E, Farghaly R (2019) The profile of plasma free amino acids in type 2 diabetes mellitus with insulin resistance: association with microalbuminuria and macroalbuminuria. Appl Biochem Biotechnol 188:854–867. https://doi.org/10.1007/s12010-019-02956-9
Shao MM, Xiang HJ, Lu H, Yin PH, Li GW, Wang YM, Chen L, Chen QG, Zhao C, Lu Q, Wu T, Ji G (2022) Candidate metabolite markers of peripheral neuropathy in Chinese patients with type 2 diabetes. Am J Transl Res 14:5420–5440
Shou J, Chen PJ, Xiao WH (2019) The Effects of BCAAs on insulin resistance in athletes. J Nutr Sci Vitaminol (Tokyo) 65:383–389. https://doi.org/10.3177/jnsv.65.383
Sirnio P, Vayrynen JP, Klintrup K, Makela J, Karhu T, Herzig KH, Minkkinen I, Makinen MJ, Karttunen TJ, Tuomisto A (2019) Alterations in serum amino-acid profile in the progression of colorectal cancer: associations with systemic inflammation, tumour stage and patient survival. Br J Cancer 120:238–246. https://doi.org/10.1038/s41416-018-0357-6
Solini A, Manca ML, Penno G, Pugliese G, Cobb JE, Ferrannini E (2016) Prediction of declining renal function and albuminuria in patients with type 2 diabetes by metabolomics. J Clin Endocrinol Metab 101:696–704. https://doi.org/10.1210/jc.2015-3345
Song L, Han R, Yin H, Li J, Zhang Y, Wang J, Yang Z, Bai J, Guo M (2022) Sphingolipid metabolism plays a key role in diabetic peripheral neuropathy. Metabolomics 18:32. https://doi.org/10.1007/s11306-022-01879-7
Stanton RC (2014) Clinical challenges in diagnosis and management of diabetic kidney disease. Am J Kidney Dis 63:S3-21. https://doi.org/10.1053/j.ajkd.2013.10.050
Sun H, Saeedi P, Karuranga S, Pinkepank M, Ogurtsova K, Duncan BB, Stein C, Basit A, Chan JCN, Mbanya JC, Pavkov ME, Ramachandaran A, Wild SH, James S, Herman WH, Zhang P, Bommer C, Kuo S, Boyko EJ, Magliano DJ (2022a) IDF Diabetes Atlas: Global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045. Diabetes Res Clin Pract 183:109119. https://doi.org/10.1016/j.diabres.2021.109119
Sun Y, Kong L, Zhang AH, Han Y, Sun H, Yan GL, Wang XJ (2022b) A hypothesis from metabolomics analysis of diabetic retinopathy: arginine-creatine metabolic pathway may be a new treatment strategy for diabetic retinopathy. Front Endocrinol (lausanne). 13:858012. https://doi.org/10.3389/fendo.2022.858012
Tofte N, Vogelzangs N, Mook-Kanamori D, Brahimaj A, Nano J, Ahmadizar F, van Dijk KW, Frimodt-Moller M, Arts I, Beulens JWJ, Rutters F, van der Heijden AA, Kavousi M, Stehouwer CDA, Nijpels G, van Greevenbroek MMJ, van der Kallen CJH, Rossing P, Ahluwalia TS, t’Hart LM (2020) Plasma metabolomics identifies markers of impaired renal function: a meta-analysis of 3089 persons with type 2 diabetes. J Clin Endocrinol Metab. https://doi.org/10.1210/clinem/dgaa173
Trifonova OP, Maslov DL, Balashova EE, Lokhov PG (2021) Mass spectrometry-based metabolomics diagnostics - myth or reality? Expert Rev Proteomics 18:7–12. https://doi.org/10.1080/14789450.2021.1893695
van der Kloet FM, Tempels FW, Ismail N, van der Heijden R, Kasper PT, Rojas-Cherto M, van Doorn R, Spijksma G, Koek M, van der Greef J, Makinen VP, Forsblom C, Holthofer H, Groop PH, Reijmers TH, Hankemeier T (2012) Discovery of early-stage biomarkers for diabetic kidney disease using ms-based metabolomics (FinnDiane study). Metabolomics 8:109–119. https://doi.org/10.1007/s11306-011-0291-6
van Hecke O, Austin SK, Khan RA, Smith BH, Torrance N (2014) Neuropathic pain in the general population: a systematic review of epidemiological studies. Pain 155:654–662. https://doi.org/10.1016/j.pain.2013.11.013
Vanweert F, de Ligt M, Hoeks J, Hesselink MKC, Schrauwen P, Phielix E (2021) Elevated plasma branched-chain amino acid levels correlate with type 2 diabetes-related metabolic disturbances. J Clin Endocrinol Metab 106:e1827–e1836. https://doi.org/10.1210/clinem/dgaa751
Wang TJ, Larson MG, Vasan RS, Cheng S, Rhee EP, McCabe E, Lewis GD, Fox CS, Jacques PF, Fernandez C, O’Donnell CJ, Carr SA, Mootha VK, Florez JC, Souza A, Melander O, Clish CB, Gerszten RE (2011) Metabolite profiles and the risk of developing diabetes. Nat Med 17:448–453. https://doi.org/10.1038/nm.2307
Wang S, Blair IA, Mesaros C (2019) Analytical methods for mass spectrometry-based metabolomics studies. Adv Exp Med Biol 1140:635–647. https://doi.org/10.1007/978-3-030-15950-4_38
Wang Y, Shao T, Wang J, Huang X, Deng X, Cao Y, Zhou M, Zhao C (2021) An update on potential biomarkers for diagnosing diabetic foot ulcer at early stage. Biomed Pharmacother 133:110991. https://doi.org/10.1016/j.biopha.2020.110991
Wang Z, Tang J, Jin E, Zhong Y, Zhang L, Han X, Liu J, Cheng Y, Hou J, Shi X, Qi H, Qian T, Yuan L, Hou X, Yin H, Liang J, Zhao M, Huang L, Qu J (2022) Serum untargeted metabolomics reveal potential biomarkers of progression of diabetic retinopathy in Asians. Front Mol Biosci 9:871291. https://doi.org/10.3389/fmolb.2022.871291
Wettersten HI, Weiss RH (2013) Applications of metabolomics for kidney disease research: from biomarkers to therapeutic targets. Organogenesis 9:11–18. https://doi.org/10.4161/org.24322
Wu G (2013) Functional amino acids in nutrition and health. Amino Acids 45:407–411. https://doi.org/10.1007/s00726-013-1500-6
Wu L, Fernandez-Loaiza P, Sauma J, Hernandez-Bogantes E, Masis M (2013) Classification of diabetic retinopathy and diabetic macular edema. World J Diabetes 4:290–294. https://doi.org/10.4239/wjd.v4.i6.290
Wu T, Qiao S, Shi C, Wang S, Ji G (2018) Metabolomics window into diabetic complications. J Diabetes Investig 9:244–255. https://doi.org/10.1111/jdi.12723
Xu C, Wu Y, Liu G, Liu X, Wang F, Yu J (2014) Relationship between homocysteine level and diabetic retinopathy: a systematic review and meta-analysis. Diagn Pathol 9:167. https://doi.org/10.1186/s13000-014-0167-y
Xuan C, Li H, Tian QW, Guo JJ, He GW, Lun LM, Wang Q (2021) Quantitative assessment of serum amino acids and association with early-onset coronary artery disease. Clin Interv Aging 16:465–474. https://doi.org/10.2147/CIA.S298743
Yamada C, Kondo M, Kishimoto N, Shibata T, Nagai Y, Imanishi T, Oroguchi T, Ishii N, Nishizaki Y (2015) Association between insulin resistance and plasma amino acid profile in non-diabetic Japanese subjects. J Diabetes Investig 6:408–415. https://doi.org/10.1111/jdi.12323
Yamaguchi N, Mahbub MH, Takahashi H, Hase R, Ishimaru Y, Sunagawa H, Amano H, Kobayashi-Miura M, Kanda H, Fujita Y, Yamamoto H, Yamamoto M, Kikuchi S, Ikeda A, Takasu M, Kageyama N, Nakamura M, Tanabe T (2017) Plasma free amino acid profiles evaluate risk of metabolic syndrome, diabetes, dyslipidemia, and hypertension in a large Asian population. Environ Health Prev Med 22:35. https://doi.org/10.1186/s12199-017-0642-7
Yamamoto R, Aso Y (2006) Synergistic association of metabolic syndrome and overt nephropathy with elevated asymmetric dimethylarginine in serum and impaired cutaneous microvasodilation in patients with type 2 diabetes. Diabetes Care 29:928–930. https://doi.org/10.2337/diacare.29.04.06.dc05-2534
Yang Z, Lou X, Zhang J, Nie R, Liu J, Tu P, Duan P (2021) Association between early markers of renal injury and type 2 diabetic peripheral neuropathy. Diabetes Metab Syndr Obes 14:4391–4397. https://doi.org/10.2147/DMSO.S335283:
Zamora Obando HR, Duarte GHB, Simionato AVC (2021) Metabolomics data treatment: basic directions of the full process. Adv Exp Med Biol 1336:243–264. https://doi.org/10.1007/978-3-030-77252-9_12
Zeng L, Yu Y, Cai X, Xie S, Chen J, Zhong L, Zhang Y (2019) Differences in serum amino acid phenotypes among patients with diabetic nephropathy, hypertensive nephropathy, and chronic nephritis. Med Sci Monit 25:7235–7242. https://doi.org/10.12659/MSM.915735
Zhang X, Lai Y, McCance DR, Uchida K, McDonald DM, Gardiner TA, Stitt AW, Curtis TM (2008) Evaluation of N (epsilon)-(3-formyl-3,4-dehydropiperidino)lysine as a novel biomarker for the severity of diabetic retinopathy. Diabetologia 51:1723–1730. https://doi.org/10.1007/s00125-008-1071-3
Zhang J, Yan L, Chen W, Lin L, Song X, Yan X, Hang W, Huang B (2009) Metabonomics research of diabetic nephropathy and type 2 diabetes mellitus based on UPLC-oaTOF-MS system. Anal Chim Acta 650:16–22. https://doi.org/10.1016/j.aca.2009.02.027
Zhang P, Lu J, Jing Y, Tang S, Zhu D, Bi Y (2017) Global epidemiology of diabetic foot ulceration: a systematic review and meta-analysis (dagger). Ann Med 49:106–116. https://doi.org/10.1080/07853890.2016.1231932
Zhang H, Zuo JJ, Dong SS, Lan Y, Wu CW, Mao GY, Zheng C (2020a) Identification of potential serum metabolic biomarkers of diabetic kidney disease: a widely targeted metabolomics study. J Diabetes Res 2020:3049098. https://doi.org/10.1155/2020/3049098
Zhang L, Zhou Y, Zhou F, Yu X, Liu J, Liu Y, Zhu Y, Wang W, Chen N (2020b) Altered expression of long noncoding and messenger RNAs in diabetic nephropathy following treatment with rosiglitazone. Biomed Res Int 2020:1360843. https://doi.org/10.1155/2020/1360843
Zhang Q, Song W, Liang X, Xie J, Shi Y, Shi X, Qiu B, Chen X (2020c) A Metabolic insight into the neuroprotective effect of Jin-Mai-Tong (JMT) decoction on diabetic rats with peripheral neuropathy using untargeted metabolomics strategy. Front Pharmacol 11:221. https://doi.org/10.3389/fphar.2020.00221
Zhang Q, Li Q, Liu S, Zheng H, Ji L, Yi N, Zhu X, Sun W, Liu X, Zhang S, Li Y, Xiong Q, Lu B (2021) Decreased amino acids in the brain might contribute to the progression of diabetic neuropathic pain. Diabetes Res Clin Pract 176:108790. https://doi.org/10.1016/j.diabres.2021.108790
Zheng Y, Ley SH, Hu FB (2018) Global aetiology and epidemiology of type 2 diabetes mellitus and its complications. Nat Rev Endocrinol 14:88–98. https://doi.org/10.1038/nrendo.2017.151
Zuvela P, Skoczylas M, Jay Liu J, Ba Czek T, Kaliszan R, Wong MW, Buszewski B, Heberger K (2019) Column characterization and selection systems in reversed-phase high-performance liquid chromatography. Chem Rev 119:3674–3729. https://doi.org/10.1021/acs.chemrev.8b00246
Acknowledgements
The authors acknowledge the financial support of the Hunan Provincial Science and Technology Department Fund, the Grant No.2021SK4030; the Major Special Project of Hunan Provincial Health and Family Planning Commission fund, the Grant No.21C0277; the Hengyang Science and Technology Department, the Grant No.202121034573.
Author information
Authors and Affiliations
Contributions
DC and BH: prepared the manuscript. SLX: conducted an internal review procedure. All authors approved the manuscript.
Corresponding author
Ethics declarations
Conflict of interest
The authors have no conflict of interest to declare.
Ethics approval
No human or animal samples were used for this study. For this reason, no informed consent was obtained from individual participants.
Additional information
Handling editor: S. Broeer.
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Cai, D., Hou, B. & Xie, S.L. Amino acid analysis as a method of discovering biomarkers for diagnosis of diabetes and its complications. Amino Acids 55, 563–578 (2023). https://doi.org/10.1007/s00726-023-03255-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00726-023-03255-8